Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2 Sell
5
-6
-55% -$5 ﹤0.01% 5118
2026
Q1
$17 Sell
11
-12
-52% -$23 ﹤0.01% 4935
2025
Q4
$49 Buy
23
+3
+15% +$10 ﹤0.01% 4706
2025
Q3
$96 Buy
20
+17
+567% +$93 ﹤0.01% 4549
2025
Q2
$17 Buy
+3
New +$24 ﹤0.01% 4857
2024
Q4
Hold
0
4405
2023
Q4
Sell
-47
Closed -$681 3169
2023
Q3
$681 Hold
47
﹤0.01% 3066
2023
Q2
$926 Hold
47
﹤0.01% 3094
2023
Q1
$330 Sell
47
-718
-94% -$11.1K ﹤0.01% 3230
2022
Q4
$15K Buy
+765
New +$6.79K ﹤0.01% 3109

Other funds holding GOCO

IFP Advisors's GOCO Position: Q2 2026 in Review

IFP Advisors reduced its GoHealth (GOCO) stake by 55% in Q2 2026, selling an estimated $5 and leaving 5 shares worth $2. The position accounts for ﹤0.01% of the portfolio, ranked #5118.

IFP Advisors first reported a position in GOCO in Q4 2022 and has held it in 9 quarters since. The position peaked at $15K in Q4 2022. 2 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • IFP Advisors held 5 shares of GoHealth worth $2 as of Q2 2026.
  • IFP Advisors sold 6 GoHealth shares in Q2 2026, an estimated $5.
  • GoHealth made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #5118 holding.
  • IFP Advisors first reported a position in GoHealth in Q4 2022 and has held it in 9 quarters since.
  • IFP Advisors's GoHealth position peaked at $15K in Q4 2022.
  • 2 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.